The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and Function
Open accessAbstract
Tuberous sclerosis (TSC) is a hamartoma syndrome attributable to mutations in either TSC1 or TSC2 in which brain involvement causes epilepsy, mental retardation, and autism. We have reported recently (Meikle et al., 2007) a mouse neuronal model of TSC in which Tsc1 is ablated in most neurons during cortical development. We have tested rapamycin and RAD001 [40-O-(2-hydroxyethyl)-rapamycin], both mammalian target of rapamycin mTORC1 inhibitors, as potential therapeutic agents in this model. Median survival is improved from 33 d to more than 100 d; behavior, phenotype, and weight gain are all also markedly improved. There is brain penetration of both drugs, with accumulation over time with repetitive treatment, and effective reduction of levels of phospho-S6, a downstream target of mTORC1. In addition, there is restoration of phospho-Akt and phospho-glycogen synthase kinase 3 levels in the treated mice, consistent with restoration of Akt function. Neurofilament abnormalities, myelination, and cell enlargement are all improved by the treatment. However, dysplastic neuronal features persist, and there are only modest changes in dendritic spine density and length. Strikingly, mice treated with rapamycin or RAD001 for 23 d only (postnatal days 7–30) displayed a persistent improvement in phenotype, with median survival of 78 d. In summary, rapamycin/RAD001 are highly effective therapies for this neuronal model of TSC, with benefit apparently attributable to effects on mTORC1 and Akt signaling and, consequently, cell size and myelination. Although caution is appropriate, the results suggest the possibility that rapamycin/RAD001 may have benefit in the treatment of TSC brain disease, including infantile spasms.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt
O'Reilly, K. E., Rojo, F., She, Q.-B., Solit, D., Mills, G. B., Smith, D., Lane, H., Hofmann, F., Hicklin, D. J., Ludwig, D. L., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2925 · Cited by 2,561
Self-citationA mammalian protein targeted by G1-arresting rapamycin–receptor complex
Brown, E. J., Albers, M. W., Bum Shin, T., ichikawa, K., Keith, C. T., Lane, W. S., & Schreiber, S. L. (1994) · Nature · doi:10.1038/369756a0 · Cited by 2,053
The Tuberous Sclerosis Complex
Crino, P. B., Nathanson, K. L., & Henske, E. P. (2006) · New England Journal of Medicine · doi:10.1056/nejmra055323 · Cited by 1,793
mTOR and cancer: insights into a complex relationship
Sabatini, D. M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1974 · Cited by 1,322
The TSC1-2 tumor suppressor controls insulin–PI3K signaling via regulation of IRS proteins
Harrington, L. S., Findlay, G. M., Gray, A., Tolkacheva, T., Wigfield, S., Rebholz, H., Barnett, J., Leslie, N. R., Cheng, S., Shepherd, P. R., et al. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200403069 · Cited by 1,123
Dabora, S. L., Jozwiak, S., Franz, D. N., Roberts, P. S., Nieto, A., Chung, J., Choy, Y.-S., Reeve, M. P., Thiele, E., Egelhoff, J. C., et al. (2001) · The American Journal of Human Genetics · doi:10.1086/316951 · Cited by 1,001
Self-citationDysregulation of the TSC-mTOR pathway in human disease
Inoki, K., Corradetti, M. N., & Guan, K.-L. (2005) · Nature Genetics · doi:10.1038/ng1494 · Cited by 972
The Akt-mTOR tango and its relevance to cancer
Hay, N. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.08.008 · Cited by 821
Shah, O. J., Wang, Z., & Hunter, T. (2004) · Current Biology · doi:10.1016/j.cub.2004.08.026 · Cited by 798
Kwiatkowski, D. J. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.5.525 · Cited by 667
Self-citationRapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.
Zeng, L., Xu, L., Gutmann, D. H., & Wong, M. (2008) · Annals of Neurology · doi:10.1002/ana.21331 · Cited by 639
Rapamycin causes regression of astrocytomas in tuberous sclerosis complex
Franz, D. N., Leonard, J., Tudor, C., Chuck, G., Care, M., Sethuraman, G., Dinopoulos, A., Thomas, G., & Crone, K. R. (2006) · Annals of Neurology · doi:10.1002/ana.20784 · Cited by 614
Zhu, Y., Romero, M. I., Ghosh, P., Ye, Z., Charnay, P., Rushing, E. J., Marth, J. D., & Parada, L. F. (2001) · Genes & Development · doi:10.1101/gad.862101 · Cited by 604
Role for Akt3/Protein Kinase Bγ in Attainment of Normal Brain Size
Easton, R. M., Cho, H., Roovers, K., Shineman, D. W., Mizrahi, M., Forman, M. S., Lee, V. M.-Y., Szabolcs, M., de Jong, R., Oltersdorf, T., et al. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.5.1869-1878.2005 · Cited by 551
Loss of Tsc1/Tsc2 activates mTOR and disrupts PI3K-Akt signaling through downregulation of PDGFR
Zhang, H., Cicchetti, G., Onda, H., Koon, H. B., Asrican, K., Bajraszewski, N., Vazquez, F., Carpenter, C. L., & Kwiatkowski, D. J. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17222 · Cited by 538
Self-citationSDZ RAD, A NEW RAPAMYCIN DERIVATIVE: Pharmacological Properties In Vitro and In Vivo
Schuler, W., Sedrani, R., Cottens, S., H??berlin, B., Schulz, M., Schuurman, H.-J., Zenke, G., Zerwes, H.-G., & Schreier, M. H. (1997) · Transplantation · doi:10.1097/00007890-199707150-00008 · Cited by 533
Jones, A. C., Shyamsundar, M. M., Thomas, M. W., Maynard, J., Idziaszczyk, S., Tomkins, S., Sampson, J. R., & Cheadle, J. P. (1999) · The American Journal of Human Genetics · doi:10.1086/302381 · Cited by 529
Control of hippocampal dendritic spine morphology through ephrin-A3/EphA4 signaling
Murai, K. K., Nguyen, L. N., Irie, F., Yamaguchi, Y., & Pasquale, E. B. (2003) · Nature Neuroscience · doi:10.1038/nn994 · Cited by 516 · cited 1×
“Spine tracing and analysis was performed as described previously (Murai et al., 2003).”
MethodRegulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2
Tavazoie, S. F., Alvarez, V. A., Ridenour, D. A., Kwiatkowski, D. J., & Sabatini, B. L. (2005) · Nature Neuroscience · doi:10.1038/nn1566 · Cited by 497 · cited 2×
“In contrast to a previous report from in vitro slice cultures (Tavazoie et al., 2005), we saw no significant change in pCofilin(S3) levels in brain extracts from the Tsc1 mice, suggesting that this actin regulatory protein had little to do with the in vivo phenotype produced by loss of Tsc1 in neurons.”
MethodResultSelf-citationSancak, O., Nellist, M., Goedbloed, M., Elfferich, P., Wouters, C., Maat-Kievit, A., Zonnenberg, B., Verhoef, S., Halley, D., & van den Ouweland, A. (2005) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5201402 · Cited by 483
Meikle, L., Talos, D. M., Onda, H., Pollizzi, K., Rotenberg, A., Sahin, M., Jensen, F. E., & Kwiatkowski, D. J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5540-06.2007 · Cited by 462
Self-citationAu, K. S., Williams, A. T., Roach, E. S., Batchelor, L., Sparagana, S. P., Delgado, M. R., Wheless, J. W., Baumgartner, J. E., Roa, B. B., Wilson, C. M., et al. (2007) · Genetics in Medicine · doi:10.1097/gim.0b013e31803068c7 · Cited by 458
Tuberin Regulates p70 S6 Kinase Activation and Ribosomal Protein S6 Phosphorylation
Goncharova, E. A., Goncharov, D. A., Eszterhas, A., Hunter, D. S., Glassberg, M. K., Yeung, R. S., Walker, C. L., Noonan, D., Kwiatkowski, D. J., Chou, M. M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202678200 · Cited by 425
Self-citationTschopp, O., Yang, Z.-Z., Brodbeck, D., Dummler, B. A., Hemmings-Mieszczak, M., Watanabe, T., Michaelis, T., Frahm, J., & Hemmings, B. A. (2005) · Development · doi:10.1242/dev.01864 · Cited by 413
Uhlmann, E. J., Wong, M., Baldwin, R. L., Bajenaru, M. L., Onda, H., Kwiatkowski, D. J., Yamada, K., & Gutmann, D. H. (2002) · Annals of Neurology · doi:10.1002/ana.10283 · Cited by 372 · cited 2×
“A conditional allele of Tsc1 has been developed and combined with different brain-specific cre recombinase alleles to generate models of TSC brain disease (Uhlmann et al., 2002; Meikle et al., 2007).”
BackgroundSelf-citationMolecular genetic advances in tuberous sclerosis
Cheadle, J. P., Reeve, M. P., Sampson, J. R., & Kwiatkowski, D. J. (2000) · Human Genetics · doi:10.1007/s004390000348 · Cited by 349
Self-citationThe TSC1 tumour suppressor hamartin regulates cell adhesion through ERM proteins and the GTPase Rho
Lamb, R. F., Roy, C., Diefenbach, T. J., Vinters, H. V., Johnson, M. W., Jay, D. G., & Hall, A. (2000) · Nature Cell Biology · doi:10.1038/35010550 · Cited by 326
mTOR, translational control and human disease
Tee, A. R., & Blenis, J. (2005) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2004.11.005 · Cited by 320
Insulin and amino-acid regulation of mTOR signaling and kinase activity through the Rheb GTPase
Avruch, J., Hara, K., Lin, Y., Liu, M., Long, X., Ortiz-Vega, S., & Yonezawa, K. (2006) · Oncogene · doi:10.1038/sj.onc.1209882 · Cited by 296
Dummler, B., Tschopp, O., Hynx, D., Yang, Z.-Z., Dirnhofer, S., & Hemmings, B. A. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00722-06 · Cited by 282
Tuberous Sclerosis Complex and Epilepsy: Recent Developments and Future Challenges
Holmes, G. L., Stafstrom, C. E., & The Tuberous Sclerosis Study Group (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01035.x · Cited by 273
mTOR cascade activation distinguishes tubers from focal cortical dysplasia
Baybis, M., Yu, J., Lee, A., Golden, J. A., Weiner, H., McKhann, G., Aronica, E., & Crino, P. B. (2004) · Annals of Neurology · doi:10.1002/ana.20211 · Cited by 255
mTor is required for hypertrophy of Pten-deficient neuronal soma in vivo
Kwon, C.-H., Zhu, X., Zhang, J., & Baker, S. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2132711100 · Cited by 235
Feedback inhibition of Akt signaling limits the growth of tumors lacking Tsc2
Manning, B. D., Logsdon, M. N., Lipovsky, A. I., Abbott, D., Kwiatkowski, D. J., & Cantley, L. C. (2005) · Genes & Development · doi:10.1101/gad.1314605 · Cited by 235
Self-citationTSC1 Stabilizes TSC2 by Inhibiting the Interaction between TSC2 and the HERC1 Ubiquitin Ligase
Chong-Kopera, H., Inoki, K., Li, Y., Zhu, T., Garcia-Gonzalo, F. R., Rosa, J. L., & Guan, K.-L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.c500451200 · Cited by 234
(1999) · doi:10.1093/oso/9780195122107.001.0001 · Cited by 174
Cognitive prognosis of patients with tuberous sclerosis complex
Winterkorn, E. B., Pulsifer, M. B., & Thiele, E. A. (2007) · Neurology · doi:10.1212/01.wnl.0000250330.44291.54 · Cited by 167
Activation of mammalian target of rapamycin in cytomegalic neurons of human cortical dysplasia
Ljungberg, M. C., Bhattacharjee, M. B., Lu, Y., Armstrong, D. L., Yoshor, D., Swann, J. W., Sheldon, M., & D’Arcangelo, G. (2006) · Annals of Neurology · doi:10.1002/ana.20949 · Cited by 160
Insulin signaling pathways in cortical dysplasia and TSC‐tubers: Tissue microarray analysis
Miyata, H., Chiang, A., & Vinters, H. V. (2004) · Annals of Neurology · doi:10.1002/ana.20234 · Cited by 154
TSC2 modulates actin cytoskeleton and focal adhesion through TSC1-binding domain and the Rac1 GTPase
Goncharova, E. A., Goncharov, D. A., Noonan, D. J., & Krymskaya, V. P. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200405130 · Cited by 116
Molecular Pathogenesis of Tuber Formation in Tuberous Sclerosis Complex
Crino, P. B. (2004) · Journal of Child Neurology · doi:10.1177/08830738040190091301 · Cited by 107
Bilanges, B., Argonza-Barrett, R., Kolesnichenko, M., Skinner, C., Nair, M., Chen, M., & Stokoe, D. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02136-06 · Cited by 79
A mouse model of cardiac rhabdomyoma generated by loss of Tsc1 in ventricular myocytes
Meikle, L. M., McMullen, J. R., Sherwood, M. C., Lader, A. S., Walker, V., Chan, J. A.-W., & Kwiatkowski, D. J. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddi039 · Cited by 77
Self-citationPrognostic Significance of Tuber Count and Location in Tuberous Sclerosis Complex
Doherty, C. P., Goh, S., Poussaint, T. Y., Erdağ, N., & Thiele, E. A. (2005) · Journal of Child Neurology · doi:10.1177/08830738050200101301 · Cited by 71
The Neurobiology of the Tuberous Sclerosis Complex
Marcotte, L. M., & Crino, P. B. (2006) · NeuroMolecular Medicine · doi:10.1385/nmm:8:4:531 · Cited by 65
Tuberous Sclerosis Complex: from basic science to clinical phenotypes
Curatolo, P. (2007) · Developmental Medicine & Child Neurology · doi:10.1111/j.1469-8749.2005.tb01114.x · Cited by 65
The Neurobiology of Tuberous Sclerosis Complex
Ess, K. C. (2006) · Seminars in Pediatric Neurology · doi:10.1016/j.spen.2006.01.009 · Cited by 50
Cellular Neuropathology of Tuberous Sclerosisa
HUTTENLOCHER, P. R., & WOLLMANN, R. L. (1991) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1991.tb37756.x · Cited by 32
Magnetization transfer ratio measurements of the brain in children with tuberous sclerosis complex
Zikou, A. K., Ioannidou, M.-C., Tzoufi, M. S., Astrakas, L. G., & Argyropoulou, M. I. (2005) · Pediatric Radiology · doi:10.1007/s00247-005-1539-y · Cited by 15
Cited by
Behavioural phenotyping assays for mouse models of autism
Silverman, J. L., Yang, M., Lord, C., & Crawley, J. N. (2010) · Nature Reviews Neuroscience · doi:10.1038/nrn2851 · Cited by 1,462
Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice
Tsai, P. T., Hull, C., Chu, Y., Greene-Colozzi, E., Sadowski, A. R., Leech, J. M., Steinberg, J., Crawley, J. N., Regehr, W. G., & Sahin, M. (2012) · Nature · doi:10.1038/nature11310 · Cited by 888
“To evaluate whether the abnormal phenotypes seen in PC Tsc1 mice were modifiable as demonstrated in other models of increased mTOR signaling 12,19,26 , we treated animals with the mTOR inhibitor, rapamycin, starting at P7.”
Henske, E. P., Jóźwiak, S., Kingswood, J. C., Sampson, J. R., & Thiele, E. A. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.35 · Cited by 831
Zoghbi, H. Y., & Bear, M. F. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a009886 · Cited by 797
“Treatment of Tsc mutant mice with the immunosuppressive drug rapamycin, an mTOR inhibitor, ameliorates several phenotypes (Meikle et al. 2008; Ehninger and Silva 2011; Tsai and Sahin 2011).”
BackgroundFrench, J. A., Lawson, J. A., Yapici, Z., Ikeda, H., Polster, T., Nabbout, R., Curatolo, P., de Vries, P. J., Dlugos, D. J., Berkowitz, N., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31419-2 · Cited by 764
Metadata
- Authors
- Meikle, L., Pollizzi, K., Egnor, A., Kramvis, I., Lane, H., Sahin, M., & Kwiatkowski, D. J.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-05-21
- Volume
- 28
- Issue
- 21
- Pages
- 5422-5432
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2056111473
- Cited by
- 501
- References
- 49
- FWCI
- 21.92
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.